TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia.

Inna M Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.